David Lonsway
About
David Lonsway is a scholar working on Clinical Biochemistry, Molecular Medicine and Infectious Diseases.
According to data from OpenAlex, David Lonsway has authored 50 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Clinical Biochemistry, 24 papers in Molecular Medicine and 21 papers in Infectious Diseases. Recurrent topics in David Lonsway's work include Bacterial Identification and Susceptibility Testing (26 papers), Antibiotic Resistance in Bacteria (24 papers) and Antimicrobial Resistance in Staphylococcus (16 papers). David Lonsway is often cited by papers focused on Bacterial Identification and Susceptibility Testing (26 papers), Antibiotic Resistance in Bacteria (24 papers) and Antimicrobial Resistance in Staphylococcus (16 papers). David Lonsway collaborates with scholars based in United States, Australia and Denmark. David Lonsway's co-authors include Brandi Limbago, Jean B. Patel, J. Kamile Rasheed, Linda K. McDougal, Fred C. Tenover, Sigrid K. McAllister, Roberta B. Carey, Bette Jensen, Karen Anderson and Arjun Srinivasan and has published in prestigious journals such as New England Journal of Medicine, Clinical Infectious Diseases and Journal of Clinical Microbiology.
In The Last Decade
David Lonsway
50 papers receiving 2.8k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| David Lonsway United States | 23 | 1.4k | 1.1k | 1.0k | 646 | 628 | 50 | 2.9k | ||
| Patricia Ruíz-Garbajosa Spain | 29 | 1.5k 1.1× | 1.0k 0.9× | 835 0.8× | 597 0.9× | 634 1.0× | 88 | 2.9k | ||
| Gunnar Skov Simonsen Norway | 39 | 1.3k 0.9× | 1.4k 1.3× | 800 0.8× | 758 1.2× | 565 0.9× | 114 | 3.7k | ||
| Isabelle Podglajen France | 34 | 1.1k 0.8× | 917 0.8× | 674 0.7× | 723 1.1× | 486 0.8× | 86 | 3.0k | ||
| D.F. Sahm United States | 28 | 1.3k 0.9× | 1.6k 1.4× | 979 1.0× | 608 0.9× | 452 0.7× | 56 | 3.4k | ||
| Eui-Chong Kim South Korea | 23 | 1.1k 0.8× | 769 0.7× | 762 0.7× | 413 0.6× | 355 0.6× | 61 | 2.8k | ||
| Panayotis T. Tassios Greece | 25 | 2.1k 1.5× | 985 0.9× | 614 0.6× | 805 1.2× | 1.0k 1.7× | 55 | 3.8k | ||
| Lalitagauri M. Deshpande United States | 34 | 2.3k 1.6× | 1.7k 1.5× | 1.0k 1.0× | 914 1.4× | 774 1.2× | 95 | 3.9k | ||
| Martin Kaase Germany | 28 | 1.5k 1.1× | 450 0.4× | 608 0.6× | 515 0.8× | 710 1.1× | 88 | 2.3k | ||
| Alejandra Corso Argentina | 29 | 1.4k 1.0× | 529 0.5× | 445 0.4× | 418 0.6× | 669 1.1× | 119 | 2.5k | ||
| Roberto G. Melano Canada | 32 | 1.6k 1.2× | 562 0.5× | 439 0.4× | 557 0.9× | 941 1.5× | 85 | 2.9k |
Countries citing papers authored by David Lonsway
Since
Specialization
Citations
This map shows the geographic impact of David Lonsway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Lonsway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Lonsway more than expected).
Fields of papers citing papers by David Lonsway
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by David Lonsway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Lonsway. The network helps show where David Lonsway may publish in the future.
Co-authorship network of co-authors of David Lonsway
This figure shows the co-authorship network connecting the top 25 collaborators of David Lonsway. A scholar is included among the top collaborators of David Lonsway based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Lonsway. David Lonsway is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
MacFarquhar, Jennifer, Teresa A. Fisher, Cathy L. Barr, et al.. (2024). Identification and Characterization of Vancomycin-Resistant Staphylococcus aureus CC45/USA600, North Carolina, USA, 2021. Emerging infectious diseases. 31(1). 194–196.
2.
Nazarian, Elizabeth, Paula Snippes Vagnone, Victoria Stone, et al.. (2021). Aztreonam-Avibactam Susceptibility Testing Program for Metallo-Beta-Lactamase-Producing Enterobacterales in the Antibiotic Resistance Laboratory Network, March 2019 to December 2020. Antimicrobial Agents and Chemotherapy. 65(8). e0048621–e0048621.
3.
Ransom, Eric M., Karen Anderson, David Lonsway, et al.. (2020). Assessing the in vitro impact of ceftazidime on aztreonam/avibactam susceptibility testing for highly resistant MBL-producing Enterobacterales. Journal of Antimicrobial Chemotherapy. 76(4). 979–983.
4.
Ransom, Eric M., Jean B. Patel, Joseph D. Lutgring, et al.. (2020). Validation of Aztreonam-Avibactam Susceptibility Testing Using Digitally Dispensed Custom Panels. Journal of Clinical Microbiology. 58(4).
5.
Heberlein-Larson, Lea, Leah D. Gillis, Andrea Morrison, et al.. (2019). Partnerships Involved in Public Health Testing for Zika Virus in Florida, 2016. Public Health Reports. 134(2_suppl). 43S–52S.
6.
Lonsway, David, Mindy G. Elrod, Rebekah Tiller, et al.. (2019). Correlation Between Etest and Reference Broth Microdilution for Antimicrobial Susceptibility Testing of Burkholderia pseudomallei. Microbial Drug Resistance. 26(4). 311–318.
7.
Shugart, Alicia, Maroya Spalding Walters, Lindsey M. Weiner, David Lonsway, & Alexander J. Kallen. (2018). Hospital microbiology laboratory practices for Enterobacteriaceae: Centers for Disease Control and Prevention National Healthcare Safety Network (NHSN) annual survey, 2015 and 2016. Infection Control and Hospital Epidemiology. 39(9). 1115–1117.
8.
Burnham, Carey‐Ann D., Bradley Ford, Sara D. Lawhon, et al.. (2015). Evaluation of an Immunochromatographic Assay for Rapid Detection of Penicillin-Binding Protein 2a in Human and Animal Staphylococcus intermedius Group, Staphylococcus lugdunensis, and Staphylococcus schleiferi Clinical Isolates. Journal of Clinical Microbiology. 54(3). 745–748.
9.
Dallas, Steven D., Lesley McGee, Brandi Limbago, et al.. (2013). Development of Doxycycline MIC and Disk Diffusion Interpretive Breakpoints and Revision of Tetracycline Breakpoints for Streptococcus pneumoniae. Journal of Clinical Microbiology. 51(6). 1798–1802.
10.
Tiller, Rebekah, Jay E. Gee, David Lonsway, et al.. (2010). Identification of an unusual Brucella strain (BO2) from a lung biopsy in a 52 year-old patient with chronic destructive pneumonia. BMC Microbiology. 10(1). 23–23.
11.
Lonsway, David, Laura A. Jevitt, James R. Uhl, et al.. (2009). Effect of Carbon Dioxide on Broth Microdilution Susceptibility Testing of Brucella spp. Journal of Clinical Microbiology. 48(3). 952–956.
12.
Swenson, Jana M., William B. Brasso, Mary Jane Ferraro, et al.. (2009). Correlation of Cefoxitin MICs with the Presence of mecA in Staphylococcus spp. Journal of Clinical Microbiology. 47(6). 1902–1905.
13.
Anderson, Karen, David Lonsway, J. Kamile Rasheed, et al.. (2007). Evaluation of Methods To Identify the Klebsiella pneumoniae Carbapenemase in Enterobacteriaceae. Journal of Clinical Microbiology. 45(8). 2723–2725.
14.
Zhu, Wenming, Fred C. Tenover, Josef Limor, et al.. (2007). Use of pyrosequencing to identify point mutations in domain V of 23S rRNA genes of linezolid-resistant Staphylococcus aureus and Staphylococcus epidermidis. European Journal of Clinical Microbiology & Infectious Diseases. 26(3). 161–165.
15.
Swenson, Jana M., David Lonsway, Sigrid K. McAllister, et al.. (2007). Detection of mecA-mediated resistance using reference and commercial testing methods in a collection of Staphylococcus aureus expressing borderline oxacillin MICs. Diagnostic Microbiology and Infectious Disease. 58(1). 33–39.
16.
Estívariz, Concepción F., Sarah Y. Park, Jeffrey Hageman, et al.. (2006). Emergence of community-associated methicillin resistant Staphylococcus aureus in Hawaii, 2001–2003. Journal of Infection. 54(4). 349–357.
17.
Tenover, Fred C., Portia P. Williams, Roberta B. Carey, et al.. (2006). Carbapenem Resistance in Klebsiella pneumoniae Not Detected by Automated Susceptibility Testing. Emerging infectious diseases. 12(8). 1209–1213.
18.
Tenover, Fred C., Portia P. Williams, Roberta B. Carey, et al.. (2006). Carbapenem Resistance in Klebsiella pneumoniae Not Detected by Automated Susceptibility Testing. Emerging infectious diseases. 12(8). 1209–1213.
19.
Shepard, Colin W., Maryam Daneshvar, Robyn Kaiser, et al.. (2004). Bordetella holmesiiBacteremia: A Newly Recognized Clinical Entity among Asplenic Patients. Clinical Infectious Diseases. 38(6). 799–804.
20.
Lonsway, David, et al.. (1990). Yersinia enterocoliticaO:3 Infections in Infants and Children, Associated with the Household Preparation of Chitterlings. New England Journal of Medicine. 322(14). 984–987.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Patricia Ruíz-Garbajosa Breakdown of academic impact, for papers by Gunnar Skov Simonsen Breakdown of academic impact, for papers by Isabelle Podglajen Breakdown of academic impact, for papers by D.F. Sahm Breakdown of academic impact, for papers by Eui-Chong Kim Breakdown of academic impact, for papers by Panayotis T. Tassios Breakdown of academic impact, for papers by Lalitagauri M. Deshpande Breakdown of academic impact, for papers by Martin Kaase Breakdown of academic impact, for papers by Alejandra Corso Breakdown of academic impact, for papers by Roberto G. Melano